Skip to content
Hair Pipeline
← Recruiting trials
NCT01650272Phase 1/2Status unknown

Efficacy and Safety Comparing 5% Monoxidil Milky Lotion Versus 5% Minoxidil Solution in Androgenetic Alopecia

An Efficacy and Safety Pilot Study Comparing 5% Monoxidil Milky Lotion Versus 5% Minoxidil Solution in Treatment of AGA

In the register

The register attaches this trial to Minoxidil (topical), currently at “Approved” in the register. The programme's phase is checked by hand; the trial's is declared by its sponsor.

What the registry records

Status
Status unknown
Declared phase
Phase 1/2
Sponsor
Siriraj Hospital
Participants (registry)
20
Start
June 2012
Primary completion
February 2013
Study completion
April 2013
Last registry update
July 2012
Countries
Thailand

Conditions studied: Objective (Goal), Self-Assessment, Adverse Effects

Interventions: 5% MInoxidil milky lotion, MInoxidil milky lotion, MInoxidil milk lotion, 5% Minoxidil solution, Minoxidil solution, Minoxidil lotion

Full record on ClinicalTrials.gov ↗

Other trials of Minoxidil (topical)

  • NCT07529977Phase 3Not yet recruiting

    Phase 3 Study to Evaluate the Efficacy and Safety of Oral Minoxidil (N1087) in Men With Androgenetic Alopecia.

  • NCT07273799Phase 3Not yet recruiting

    Comparison of Outcomes Between Topical Minoxidil Versus Oral Minoxidil for the Treatment of Androgenetic Alopecia

  • NCT06924632Phase 3Completed

    Efficacy & Safety of Minoxidil SL Tablets in Men With AGA

  • NCT07056933Not yet recruiting

    Effect of Minoxidil Solution Iontophoresis on Androgenic Alopecia

  • NCT07012486Early phase 1Recruiting

    Efficacy of Dihydroartemisinin for Treating Female Androgenetic Alopecia

  • NCT07080931Phase 3Recruiting

    Efficacy and Safety of 5% Minoxidil Foam in Female Androgenetic Alopecia

  • NCT07076706Phase 2Completed

    Clinical Trial to Evaluate CG2001 in Chinese Adult Male Participants With Androgenetic Alopecia

  • NCT05888922Phase 3Active, not recruiting

    Evaluation of Efficacy and Safety of Oral Minoxidil 1 mg in Female Androgenetic Alopecia

  • NCT06043349Phase 4Status unknown

    Effectiveness and Safety of Platelet-rich Plasma and Topical 5% Minoxidil Combination in Male Androgenetic Alopecia

  • NCT04721548Phase 3Completed

    Treatment of Androgenetic Alopecia in Men for 24 Weeks

  • NCT05296863Phase 3Completed

    Adipose-derived Stem Cell Conditioned Media as a Novel Approach for Hair Regrowth in Male Androgenetic Alopecia

  • NCT02486848Withdrawn

    Minoxidil Dose Response Study in Females Identified Through IVD Testing as Non-Responders to 5% Topical Minoxidil

Listing a trial is not a recommendation to join one. Eligibility, risks and costs vary enormously — discuss any trial with your own doctor first. A registration proves a sponsor declared a study, not that it is progressing or will succeed. We're not doctors.